• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Authors



Reyan Ghany, MD

Latest:

High-Touch Care Leads to Better Outcomes and Lower Costs in a Senior Population

Evaluating the impact of a high-touch primary care model among a Medicare Advantage population in comparison with a standard practice–based model. Check out our website’s new table/figure pop-up feature! Click on the name of a table or figure in the text to see it in your browser.


Eric W. Ford, PhD, MPH

Latest:

Electronic Reminder's Role in Promoting Human Papillomavirus Vaccine Use

The use of the electronic health record’s clinical reminder functionality is systematically related to higher human papillomavirus vaccine administration rates.



Michael E. Klepser, PharmD

Latest:

Cost-Effectiveness of Pharmacist-Provided Treatment of Adult Pharyngitis

This cost-effectiveness analysis of care options for group A streptococcus patients is the first to include community pharmacy as a possible point of care.


Elizabeth G. Liles, MD, MSCR

Latest:

Change to FIT Increased CRC Screening Rates: Evaluation of a US Screening Outreach Program

Fecal immunochemical testing resulted in higher colorectal cancer screening rates than did guaiac fecal occult blood tests, with less dependence on office visits.


Mia D. Croyle, MA

Latest:

A Team Approach to Systematic Behavioral Screening and Intervention

Expanding primary care teams with trained and supported paraprofessionals enables systematic delivery of widely recommended, evidence-based, cost-saving alcohol, drug, and depression screening and intervention services.




Daren Anderson, MD

Latest:

A Cost-Effectiveness Analysis of Cardiology eConsults for Medicaid Patients

A randomized trial of eConsults for cardiology referrals from primary care resulted in significant reductions in total cost of care compared with traditional face-to-face consultations.


ttker, MPH

Latest:

Gender Differences in Healthcare Utilization of Patients With Diabetes

Gender differences were found in healthcare utilization in patients with type 2 diabetes mellitus in Germany, despite a high rate of enrollment in a disease management program.



Michael J. Cangelosi, MA, MPH

Latest:

Potential Role of Network Meta-Analysis in Value-Based Insurance Design

This study illustrates that where clinical trials are lacking, network meta-analysis can provide valuable insights into the potential clinical and economic benefits of value-based insurance design.


Kelly H. Zou, PhD

Latest:

Utilization Management for Smoking Cessation Pharmacotherapy: Varenicline Rejected Claims Analysis

About half of the patients in this study did not fill any smoking cessation medication following a rejected claim for varenicline.


Emily Alexy, MPH

Latest:

Implications of Eligibility Category Churn for Pediatric Payment in Medicaid

Analyses of Ohio Medicaid claims data from 2013 to 2015 reveal that instability among eligibility categories is common and affects average capitation but not health service use.


Haim Reuveni, MD

Latest:

Disease Management Programs: Barriers and Benefits

Perceived barriers and benefits to implementing disease management programs among Israeli healthcare leaders could assist other countries faced with increasing numbers of chronically ill patients.










Risha Gidwani, DrPH

Latest:

Differences in Telehealth During COVID-19 Between Commercial and Medicaid Enrollees

Differences in use of telehealth between commercial and Medicaid populations during the COVID-19 pandemic are associated with managed care enrollment.





Yujin Park, PharmD

Latest:

Placement of Selected New FDA-Approved Drugs in Medicare Part D Formularies, 2009-2013

There is significant heterogeneity in formulary placement and restrictions on new drug approvals in the Part D marketplace.


Adam J. Rose, MD, MSc

Latest:

Gender Differences in Prescribing of Zolpidem in the Veterans Health Administration

We found inappropriate prescribing of zolpidem, in terms of both guideline-discordant dosage and coprescribing with benzodiazepines, with female veterans affected more than male veterans.

© 2025 MJH Life Sciences
AJMC®
All rights reserved.